ALX ONCOLOGY HOLDINGS INC 10-Q filing
Filed 2025-11-07 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-272281
- Form type
- 10-Q
- CIK
- 0001810182
- Primary document
- https://www.sec.gov/Archives/edgar/data/1810182/000119312525272281/alxo-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ALX ONCOLOGY HOLDINGS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-81.0M | - | - |
| Net Income | $-78.8M | - | - |
| Eps Basic | -1.48 | - | - |
| Eps Diluted | -1.48 | - | - |
| Cash And Equivalents | $23.4M | - | - |
| Total Assets | $82.7M | - | - |
| Total Liabilities | $37.9M | - | - |
| Shareholders Equity | $44.8M | - | - |
| Operating Cash Flow | $-65.2M | - | - |
| Capital Expenditures | $163,000 | - | - |